Fluoroquinolones - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Systemic and inhaled fluoroquinolone antibiotics – reminder on restrictions of use

Key facts

• Active substance:
  Fluoroquinolones
• Therapeutic area (MeSH):
  Anti-Bacterial Agents
• Procedure number:
  SC01/EMA/2018/29/PE
• Regulatory outcome:
  Variation
• DHPC type:
  Post-authorisation measure
• Dissemination date:
  08/06/2023